Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 3/20 | 0.54 |
| ▸ | TXNRD1 | Q16881 | 3/20 | 0.54 |
| ▸ | AURKA | O14965 | 2/20 | 0.54 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.54 |
| ▸ | TXNRD3 | Q86VQ6 | 2/20 | 0.54 |
| ▸ | TXNRD2 | Q9NNW7 | 2/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 4/20 | 0.44 |
| ▸ | BLM | P54132 | 4/20 | 0.44 |
| ▸ | USP2 | O75604 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6407772 | 0.75 | S100A4 (0.44) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| SCHEMBL7179176 | 0.75 | CDC25B (0.44) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| SCHEMBL29145973 | 0.74 | MAPT (0.40) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| SCHEMBL15478974 | 0.72 | S100A4 (0.41) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| Naphthazalin SCHEMBL149279 | 0.71 | TXNRD1 (1.00) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| Naphthazalin SCHEMBL27700955 | 0.71 | TXNRD1 (1.00) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| Naphthazalin SCHEMBL29353283 | 0.71 | TXNRD1 (1.00) | CDC25BTXNRD1AURKAAURKBTXNRD3 | |
| SCHEMBL6409655 | 0.71 | TOP1 (0.49) | CDC25BTXNRD1TXNRD3TXNRD2MEN1 | |
| SCHEMBL7177840 | 0.70 | S100A4 (0.41) | CDC25BMEN1KMT2AALDH1A1HPGD | |
| Naphthazalin SCHEMBL21403377 | 0.69 | TXNRD1 (0.94) | CDC25BTXNRD1AURKAAURKBTXNRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0804163-B1 | IMPROVED METHOD FOR STABILIZATION OF BIOLOGICAL SUBSTANCES DURING DRYING AND SUBSEQUENT STORAGE AND COMPOSITIONS THEREOF | ELAN DRUG DELIVERY LTD (GB) | 2003-11-12 | — | — | EP | claimed |
| US-6313102-B1 | STABILIZED DRY COMPOSITION COMPRISING THERAPEUTIC AGENT SUSCEPTIBLE TO MAILLARD REACTION, FURTHER COMPRISING REDUCING CARBOHYDRATE AS STABILIZER FOR THERAPEUTIC AGENT AND INHIBITOR OF MAILLARD REACTION | QUARDRANT HOLDINGS CAMBRIDGE, LTD. (GB) | 2001-11-06 | — | — | US | claimed |
| US-6290991-B1 | POLYOL AND A BIOACTIVE AGENT WHEREIN SAID POLYOL IS AMORPHOUS OR NON-CRYSTALLINE AND STABILIZES SAID BIOACTIVE AGENT, AND WHEREIN SAID THERAPEUTIC COMPOSITION IS A POWDER SUITABLE FOR ADMINISTRATION BY INHALATION | QUANDRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 2001-09-18 | — | — | US | claimed |
| US-5955448-A | Method for stabilization of biological substances during drying and subsequent storage and compositions thereof | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1999-09-21 | — | — | US | claimed |
| EP-0804163-A1 | IMPROVED METHOD FOR STABILIZATION OF BIOLOGICAL SUBSTANCES DURING DRYING AND SUBSEQUENT STORAGE AND COMPOSITIONS THEREOF | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1997-11-05 | — | — | EP | claimed |
| CN-1160345-A | Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof | QUADRANT HOLDINGS CAMBRIDGE (GB) | 1997-09-24 | — | — | CN | claimed |
| EP-0433679-B1 | Pharmaceutical compositions for inhibition of maillard's reaction | SENJU PHARMA CO (JP) | 1997-05-02 | — | — | EP | claimed |
| WO-1996005809-A1 | IMPROVED METHOD FOR STABILIZATION OF BIOLOGICAL SUBSTANCES DURING DRYING AND SUBSEQUENT STORAGE AND COMPOSITIONS THEREOF | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1996-02-29 | — | — | WO | claimed |
| EP-0433679-A2 | Pharmaceutical compositions for inhibition of maillard's reaction | Senju Pharmaceutical Co., Ltd. (JP) | 1991-06-26 | — | — | EP | claimed |
| EP-2395073-B1 | Drying process | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2017-09-06 | — | — | EP | disclosed |
| EP-1556477-B1 | DRYING PROCESS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2017-08-09 | — | — | EP | disclosed |
| US-8449865-B2 | Drying process | GLAXOSMITHKLINE BIOLOGICALS SA. (BE) | 2013-05-28 | — | — | US | disclosed |
| US-8409587-B2 | Immunogenic composition | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2013-04-02 | — | — | US | disclosed |
| US-8173411-B2 | Drying process for preserving an active agent as a highly viscous liquid | GLAXOSMITHKLINE BIOLOGICALS S.A. (BE) | 2012-05-08 | — | — | US | disclosed |
| EP-0755249-A1 | USE OF MAILLARD REACTION INHIBITORS FOR THE TREATMENT OF AMYLOIDOSIS-BASED DISEASE | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1997-01-29 | — | — | EP | disclosed |
| WO-1996040077-A2 | METHODS FOR STABLY INCORPORATING SUBSTANCES WITHIN DRY, FOAMED GLASS MATRICES AND COMPOSITIONS OBTAINED THEREBY | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996005809-A1 | IMPROVED METHOD FOR STABILIZATION OF BIOLOGICAL SUBSTANCES DURING DRYING AND SUBSEQUENT STORAGE AND COMPOSITIONS THEREOF | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1996-02-29 | — | — | WO | disclosed |
| WO-1996003978-A1 | SOLID DELIVERY SYSTEMS FOR CONTROLLED RELEASE OF MOLECULES INCORPORATED THEREIN AND METHODS OF MAKING SAME | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1996-02-15 | — | — | WO | disclosed |
| WO-1995028151-A1 | USE OF MAILLARD REACTION INHIBITORS FOR THE TREATMENT OF AMYLOIDOSIS-BASED DISEASE | QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) | 1995-10-26 | — | — | WO | disclosed |
| EP-0433679-A2 | Pharmaceutical compositions for inhibition of maillard's reaction | Senju Pharmaceutical Co., Ltd. (JP) | 1991-06-26 | — | — | EP | disclosed |